Three gastroenterology leaders making headlines:
GI & Endoscopy
Takedea will acquire PvP Biologics after the company reports results from its phase 1 proof-of-mechanism study of its treatment for uncontrolled celiac disease.
Consolidation is rippling through healthcare, making its mark across an array of specialties, and gastroenterology is no different, according to an analysis from STAT.
Here are eight updates from gastroenterology companies and practices from the past week:
Three new gastroenterology-focused ASCs, facilities opened or announced this month:
Perardi Development is building a medical office building in Austin, Texas, which a gastroenterology-facing tenant is expected to lease space in, Patch reports.
Fujifilm Europe will launch its real-time colonic polyp detection tool Cad Eye in Europe after receiving a CE mark.
Here are eight things to know about the gastroenterology and surgery center markets.
Five must-read articles for gastroenterologists this week:
A 29-year-old gastroenterologist practicing in Wuhan, China has died from coronavirus, according to the New York Times.
